NCT01185509View on ClinicalTrials.gov

Trastuzumab and Vinorelbine in Advanced Breast Cancer

PHASE2TerminatedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

January 31, 2017

Study Completion Date

January 31, 2018

Conditions
Breast CancerMetastatic Breast Cancer
Interventions
DRUG

trastuzumab

DRUG

vinorelbine

Trial Locations (3)

02114

Massachusetts General Hospital, Boston

02115

Beth Israel Deaconess Medical Center, Boston

02215

Dana-Farber Cancer Institute, Boston

Sponsors

Collaborators (1)

Genentech, Inc.
All Listed Sponsors
collaborator

Brigham and Women's Hospital

OTHER

collaborator

Beth Israel Deaconess Medical Center

OTHER

collaborator

Massachusetts General Hospital

OTHER

collaborator

Genentech, Inc.

INDUSTRY

lead

Dana-Farber Cancer Institute

OTHER